Aller au contenu principal
Profil bibliographique

Ting‐Tsung Chang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

85Publications signalées
7537Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Hepatitis C virus researchHepatitis B Virus StudiesLiver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer Studies

Les publications récentes

Accès ouvert 2025 article OpenAlex

The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients

Wei Teng, Ting‐Tsung Chang, Chien‐Wei Su, Jie Xu et autres

OBJECTIVES: This study investigated the impact and related mechanisms of single-nucleotide variants (SNVs) in the HBV pre-S/S region on tumor development, and evaluated the role of antiviral therapy. METHODS: A retrospective analysis was conducted in 104 patients of the gray zone. HCC-associated …

tw (code pays fourni par la source)

1 citation Journal of Biomedical Science
Accès ouvert 2025 article OpenAlex

Intratumoral microbiome composition and its role in tumor recurrence in primary liver cancer

Wen‐Chun Liu, Hsin‐Yu Kuo, Hung‐Wen Tsai, Yih‐Jyh Lin et autres

BACKGROUND: The human microbiome is increasingly recognized as a factor in cancer development, though its role in primary liver cancer (PLC) remains unclear. This retrospective cohort study examines tissue-specific microbiota differences between hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), and explores their association …

tw (code pays fourni par la source)

6 citations Journal of the Formosan Medical Association
Accès ouvert 2025 article OpenAlex

Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study

Edward Gane, Ewa Janczewska, Tetsuo Takehara, Wan‐Long Chuang et autres

Background & aims Previous studies showed combination treatment with short interfering RNA JNJ-73763989 (JNJ-3989)±capsid assembly modulator bersacapavir (JNJ-56136379) and nucleos(t)ide analogs (NAs) was well tolerated by chronic hepatitis B (CHB) patients, with JNJ-3989 dose-dependent reductions in viral markers, including hepatitis B surface …

nz, jp, tw, pl, us, au, be (code pays fourni par la source)

1 citation JHEP Reports
Accès ouvert 2025 article OpenAlex

Development of an NGS‐Based Estimation of Integrated HBV DNA in Liver Biopsies and Detection in Liquid Biopsies

Hsin‐Ni Liu, Selena Y. Lin, Ricardo Ramírez, Shin‐En Chen et autres

This study characterized a hepatitis B virus (HBV) hybridization-capture next-generation sequencing (HBV-NGS) assay and applied it to develop a model for estimating the integrated HBV DNA (iDNA) quantity and for HBV genetics liquid biopsy. Using HBV monomers and reconstituted cell line DNA …

us, tw (code pays fourni par la source)

2 citations Journal of Medical Virology
Accès ouvert 2025 article OpenAlex

HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation

C. Chiang, Yih‐Jyh Lin, Wen‐Chun Liu, Ting‐Tsung Chang et autres

The posttransplantation recurrence rate of hepatitis B virus (HBV) infection in patients with chronic hepatitis B (CHB) is underestimated and linked with unfavorable outcomes. We investigated HBV recurrence by serum assays in patients with CHB following liver transplantation. We enrolled patients with …

tw (code pays fourni par la source)

0 citations Journal of Medical Virology
Accès ouvert 2025 review OpenAlex

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies

Richard S. Finn, Kangsheng Gu, Xi Chen, Philippe Merle et autres

Background & Aims: We performed a meta-analysis of data from the KEYNOTE-240 and KEYNOTE-394 studies to obtain a more precise estimate of the pembrolizumab treatment effect in participants with previously treated advanced hepatocellular carcinoma (HCC). Methods: Participants with confirmed HCC and disease …

us, cn, fr, kr, tw, jp (code pays fourni par la source)

10 citations JHEP Reports
2024 conference-paper OpenAlex

IDDF2024-ABS-0205 Impact of long-term treatment with continuous tenofovir alafenamide (TAF) or after switch from tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB)

Young‐Suk Lim, Grace Wong, Sang Hoon Ahn, Wai Kay Seto et autres

Background In an integrated analysis of 2 global Phase 3 studies, we evaluated HCC incidence and risk at 8 years in patients treated with TAF and those treated initially with TDF and then switched to TAF for up to 6 years (y). …

kr, hk, gb, ca, us, tw, in, it, cn, sg, fr, nz, es (code pays fourni par la source)

1 citation
2024 conference-abstract OpenAlex

Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study.

Lorenza Rimassa, Daneng Li, Masafumi Ikeda, Mark Yarchoan et autres

484 Background: Combinations of a PD-1/L1 inhibitor with a CTLA-4 or VEGF inhibitor have been approved as 1L treatment options for pts with advanced HCC. The multicenter, phase 2 KEYSTEP-004 study (NCT04740307) was conducted to evaluate the coformulation of quavonlimab (CTLA-4 inhibitor) …

it, us, jp, kr, ch, tw, cn, es (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2023 article OpenAlex

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Selena Y. Lin, Wei Xia, Amy K. Kim, Dion Chen et autres

An optimized hepatocellular carcinoma (HCC)-targeted methylation next generation sequencing assay was developed to discover HCC-associated methylation markers directly from urine for HCC screening. Urine cell-free DNA (ucfDNA) isolated from a discovery cohort of 31 non-HCC and 30 HCC was used for biomarker …

us, tw (code pays fourni par la source)

11 citations Scientific Reports
Accès ouvert 2023 article OpenAlex

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Young‐Suk Lim, Henry Lik‐Yuen Chan, Sang Hoon Ahn, Wai Kay Seto et autres

Background & Aims Antiviral therapy may attenuate the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). We aimed to explore how tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) affect HCC risk in patients with CHB. Methods The …

kr, hk, cn, gb, ca, nl, tw, jp, in, it, sg, us, nz, es (code pays fourni par la source)

21 citations JHEP Reports
Accès ouvert 2023 article OpenAlex

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Hsueh‐Chien Chiang, Yang-Cheng Lee, Ting‐Tsung Chang, Yih‐Jyh Lin et autres

Immune checkpoint inhibitors (ICIs) combined with multitarget tyrosine kinase inhibitors (MTKIs) exert a synergistic effect and are effective in unresectable hepatocellular carcinoma (uHCC). However, precise data regarding the real-world clinical applications of these combination therapies in uHCC are lacking. This study compared …

tw (code pays fourni par la source)

6 citations Cancers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.